The elementary fusion modalities of osteoclasts

Bone

Volumn 73, Issue , 2015, Pages 181-189

  Søe, Kent ^a   Hobolt Pedersen, Anne Sofie ^a   Delaisse, Jean Marie ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Fusion; Fusion partner; Heterogeneity; Mobility; Osteoclast fusion

Indexed keywords

ARTICLE; CELL FUSION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELL SURFACE; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MALE; MONONUCLEAR CELL; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PHAGOCYTE; CYTOLOGY;

CELL FUSION; HUMANS; OSTEOCLASTS;

EID: 84920936192     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.12.010     Document Type: Article

References (41)

1. Inoue N., Ikawa M., Okabe M. The mechanism of sperm-egg interaction and the involvement of IZUMO1 in fusion. Asian J Androl 2011, 13:81-87.
2. Dupressoir A., Lavialle C., Heidmann T. From ancestral infectious retroviruses to bona fide cellular genes: role of the captured syncytins in placentation. Placenta 2012, 33:663-671.
3. Huppertz B., Bartz C., Kokozidou M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron 2006, 37:509-517.
4. Abmayr S.M., Pavlath G.K. Myoblast fusion: lessons from flies and mice. Development 2012, 139:641-656.
5. Hindi S.M.T. Signaling mechanisms in mammalian myoblast fusion. Sci Signal 2013, 6:re2.
6. Oursler M.J. Recent advances in understanding the mechanisms of osteoclast precursor fusion. J Cell Biochem 2010, 110:1058-1062.
7. Piper K., Boyde A., Jones S.J. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro. Anat Embryol (Berl) 1992, 186:291-299.
8. Ralston S., Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int 2012, 91:97-113.
9. Jobke B., Milovanovic P., Amling M., Busse B. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Bone 2014, 59:37-43.
10. Iwasaki R., Ninomiya K., Miyamoto K., Suzuki T., Sato Y., Kawana H., et al. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys Res Commun 2008, 377:899-904.
11. Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 2004, 200:941-946.
12. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005, 202:345-351.
13. Han X., Sterling H., Chen Y., Saginario C., Brown E.J., Frazier W.A., et al. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 2000, 275:37984-37992.
14. Hobolt-Pedersen A.S., Delaisse J.M., Soe K. Osteoclast fusion is based on heterogeneity between fusion partners. Calcif Tissue Int 2014, 95:73-82.
15. Lundberg P., Koskinen C., Baldock P.A., Lothgren H., Stenberg A., Lerner U.H., et al. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRP+|-interaction. Biochem Biophys Res Commun 2007, 352:444-448.
16. Barrow A.D., Raynal N., Andersen T.L., Slatter D.A., Bihan D., Pugh N., et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest 2011, 121:3505-3516.
17. Shin N.Y., Choi H., Neff L., Wu Y., Saito H., Ferguson S.M., et al. Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts. J Cell Biol 2014, 207:73-89.
18. Miyamoto H., Suzuki T., Miyauchi Y., Iwasaki R., Kobayashi T., Sato Y., et al. Osteoclast stimulatory transmembrane protein and dendritic cell-specific transmembrane protein cooperatively modulate cell-cell fusion to form osteoclasts and foreign body giant cells. J Bone Miner Res 2012, 27:1289-1297.
19. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2007, 12:1403-1409.
20. Soe K., Andersen T.L., Hobolt-Pedersen A.S., Bjerregaard B., Larsson L.I., Delaisse J.M. Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion. Bone 2011, 48:837-846.
21. Chiu Y.H., Mensah K.A., Schwarz E.M., Ju Y., Takahata M., Feng C., et al. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 2012, 27:79-92.
22. Ishii M., Saeki Y. Osteoclast cell fusion: mechanisms and molecules 4. Mod Rheumatol 2008, 18:220-227.
23. Mensah K.A., Ritchlin C.T., Schwarz E.M. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol 2010, 223:76-83.
24. Aguilar P.S., Baylies M.K., Fleissner A., Helming L., Inoue N., Podbilewicz B., et al. Genetic basis of cell-cell fusion mechanisms. Trends Genet 2013, 29:427-437.
25. Oren-Suissa M., Podbilewicz B. Cell fusion during development. Trends Cell Biol 2007, 17:537-546.
26. Baron R., Neff L., Tran V.P., Nefussi J.R., Vignery A. Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 1986, 122:363-378.
27. Mizoguchi T., Muto A., Udagawa N., Arai A., Yamashita T., Hosoya A., et al. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol 2009, 184:541-554.
28. Bjerregard B., Ziomkiewicz I., Schulz A., Larsson L.I. Syncytin-1 in differentiating human myoblasts: relationship to caveolin-3 and myogenin. Cell Tissue Res 2014, 357:355-362.
29. Pavlath G.K. Spatial and functional restriction of regulatory molecules during mammalian myoblast fusion. Exp Cell Res 2010, 316:3067-3072.
30. Drewlo S., Leyting S., Kokozidou M., Mallet F., Potgens A.J.G. C-terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. Biol Chem 2006, 387:1113-1120.
31. Hayward M.D., Potgens A.J., Drewlo S., Kaufmann P., Rasko J.E. Distribution of human endogenous retrovirus type W receptor in normal human villous placenta. Pathology 2007, 39:406-412.
32. Noorali S., Rotar I.C., Lewis C., Pestaner J.P., Pace D.G., Sison A., et al. Role of HERV-W syncytin-1 in placentation and maintenance of human pregnancy. Appl Immunohistochem Mol Morphol 2009, 17:319-328.
33. Zhang C., Dou C., Xu J., Dong S. DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis. J Cell Physiol 2014, 229:1330-1335.
34. Maile L.A., DeMambro V.E., Wai C., Aday A.W., Capps B.E., Beamer W.G., et al. An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. J Bone Miner Res 2011, 26:2068-2081.
35. Uluckan O., Becker S.N., Deng H., Zou W., Prior J.L., Piwnica-Worms D., et al. CD47 regulates bone mass and tumor metastasis to bone. Cancer Res 2009, 69:3196-3204.
36. Takito J., Nakamura M., Yoda M., Tohmonda T., Uchikawa S., Horiuchi K., et al. The transient appearance of zipper-like actin superstructures during the fusion of osteoclasts. J Cell Sci 2012, 125:662-672.
37. Takito J., Otsuka H., Yanagisawa N., Arai H., Shiga M., Inoue M. Regulation of osteoclast multinucleation by the actin cytoskeleton signaling network. J Cell Physiol 2014, [in press]. 10.1002/jcp.24723.
38. Oikawa T., Oyama M., Kozuka-Hata H., Uehara S., Udagawa N., Saya H., et al. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J Cell Biol 2012, 197:553-568.
39. Sens K.L., Zhang S., Jin P., Duan R., Zhang G., Luo F., et al. An invasive podosome-like structure promotes fusion pore formation during myoblast fusion. J Cell Biol 2010, 191:1013-1027.
40. Helming L., Winter J., Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci 2009, 122:453-459.
41. Sun X., Whittaker G. Entry of influenza virus. Viral Entry into Host Cells 2013, 72-82. Springer, New York. S. Pohlmann, G. Simmons (Eds.).